Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Top 100 Creative Companies

AstraZeneca AZ

AZ bags key lung cancer approval for Imfinzi

Becomes the first PD-1/PD-L1 inhibitor approved to treat inoperable stage III NSCLC patients

- PMLiVE

A marathon and a sprint

Customer experience is a long-distance race and with pharma late out of the blocks, companies need to put their foot down if they want to compete

Roche Basel Switzerland

Roche to buy cancer data firm Flatiron for $1.9bn

Data provides a wealth of RWE opportunities

- PMLiVE

Merck/Pfizer’s cancer immunotherapy latecomer hits a snag

Bavencio fails a key lung cancer trial

- PMLiVE

Arthritis patient group launches interactive video initiative

NRAS hopes its Love Your Heart programme will lower CV risks in those with RA

- PMLiVE

Love Your Heart: An Innovative Interactive Video Programme

NRAS Launches 'Love Your Heart' Interactive Video Programme. A new initiative aims to decrease cardiovascular risk for people with Rheumatoid Arthritis.

Streaming Well

- PMLiVE

J&J’s Erleada first US drug for non-metastatic prostate cancer

Drug approved by the FDA on the back of data from the SPARTAN study

Bristol-Myers Squibb (BMS) building

BMS pens massive $3.6bn deal for Nektar cancer immunotherapy

Nektar’s NKTR-214 to be paired with Opdivo and Yervoy in a host of tumour types

- PMLiVE

Trio of new starters for Wave

Lucy Noble, Ella Withey and Maria Cain join the UK med ed agency

- PMLiVE

McCann Health appoints Daniel Carucci as global medical director

The newly-created position will see him work across McCann's global network

Finding the patient voice

How patients feel and speak about clinical trials

Six Degrees Medical

Six Degrees Medical Consulting

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links